IFM Therapeutics looks to inhibit STING to treat autoimmune disease

Monday, February 11, 2019 - 07:50 in Health & Medicine

The Boston firm, which previously developed STING activators for cancer immunotherapy, now plans to tackle the same drug target for different diseases

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net